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Abstract: 
This paper summarises the effectiveness of tissue adhesives in otorhinolaryngology. 
Although the adhesion system cannot and should not replace surgical suture, it provides 
valuable assistance in tissue synthesis and in local haemostasis, particularly in cases where 
conventional suture methods are especially difficult to apply. In addition to good adhesion, 
an elastic consistency, and good tissue compatibility, the adhesive is completely absorbed. 
The system has been used successfully in myringoplasty, laryngectomy during pharyngeal 
closure, repair of CSF leak, laryngocele, and ossiculoplasty. 
Introduction: 
The idea to use adhesives for wound closure or to stabilize and fix tissues can be traced back 
to many centuries. After the use of different adhesives and glutinous substances (pitch, bee 
wax, natural rubber) for wound cover with more or less good results, the development of 
fibrin glues (1940) and the later cyanoacrylates (1960) offered new ways in tissue adhesion.  
         The gold standard of wound closure, the suture, becomes less possible because of 
Continuous miniaturisation and the development of minimally invasive surgery methods, 
particularly in mucosal areas. But a sufficient wound closure, a secured fixation of skin 
grafts, transplants and implants can be of vital importance for the success of a surgical 
therapy. In these areas, tissue adhesives virtually present themselves as method of choice. 
Gluing ensures a constant laminar force spreading. Unevenness of the material can be www.jorl.net 
 
compensated by the adhesive. Additionally to mechanical and chemical basics of adhesion, 
the characteristics of a living system must be considered for medical application. 
The requirements of medical tissue adhesive:  
Biocompatibility:  
-Biodegradation and resorbability in a defined period  
-no local or systemic toxicity, carcinogenicity or teratogenicity of the adhesives or its  
degradation products  
-marginal heat development during hardening.  
Compound strength:  
-high bond strength in wet environment with immediate functional stress  
-adequate elasticity 
Application:  
-easy preparation  
-adequate flow characteristics and curing times  
-application systems for different areas of application  
-miniaturisation (microscopic and endoscopic surgical methods)  
Others:  
-Sterilisability  
-Stable to storage 
 
Materials and methods: 
A study was conducted in Stanley medical college and hospital from 2009 to 2011. Tissue 
glue was used in various surgeries like myringoplasty, total laryngectomy (pharyngeal 
closure), repair of CSF leak and laryngocele and the effectiveness was evaluated. We used 
Biologic tissue adhesive, ‘Tisseel’ a two component fibrin sealant. 
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Tisseel kit contains:  
Tisseel, lyophized, stream treated sealer protein concentrate, human 1 ml of Tisseel solution 
contains   
Clottable protein                   75- 115 mg  
Thereof fibrinogen              70-110 mg   
Plasma fibrinogen (CIG)     2-9 mg   
Factor  XIII                             10-15 IU  
Plasminogen                          40-120 ug  
Aprotinin solution bovine, 3000 KIU/ml  
Thrombin 4 lyophized, human 1 ml of thrombin solution contains   
Thrombin 4 IU   
Thrombin 500 lyophized, human 1 ml of thrombin solution contains   
Thrombin 500 IU  
Calcium chloride solution 40 mmol/l  
Kits for reconstruction and application. 
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Image showing TISSEEL KIT 
 
Image showing syringe used for tissue glue application 
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Mechanism of adhesion: 
1  
       The components thrombin and fibrinogen cause, analogue to the last phase of blood 
coagulation, the formation of cross-linked fibrin. Here, the concentration of fibrinogen is 15 
to 25 times higher than in circulating plasma. Therefore, fibrin is formed much faster. The 
other key factor is factor XIII, which causes an indissoluble fibrin matrix. Besides, most fibrin 
glues contain anti-fibrinolytic substances (tranexamic acid, aprotinin), which are responsible 
for stabilisation of the adhesion by inhibition of fibrinolysis.  
1,2 It is elaborated in detail in 
discussion. 
 
Image describing reconstruction process 
 
Reconstruction and application:  
Use Tisseel and Thrombin solution within 4 hrs. after reconstitution.  
Caution:  
   Use separate syringes and needles for reconstitution of Tisseel and thrombin.  
   Use again separate syringes and needles for their application.  
   Do not inject by the intravenous route.   
 
 
 
 
 
 www.jorl.net 
 
Application:    
Study 1:  
        This fibrin glue was used in 10 cases of myringoplasty.  7 Myringoplasty was done as 
classical underlay technique. Graft was placed lateral to the handle of malleus and fibrin 
glue was applied at the margins of the tympanomeatal flap after it was repositioned. And 
those cases were followed up for a period of 6 months (once in every month) and the cases 
were evaluated by otoendoscopy and pure tone audiometry.   
 Otoendoscopy was done and the following features were assessed:  
Graft taken up or not.  
Graft medialisation.   
Graft lateralisation.          
Results:  Graft was taken up in 9 out of 10 cases. There is neither lateralisation nor 
medialisation of the graft. Pure tone audiometry was showed there was improvement in air 
bone gap. 
 
Study 2:    
Fibrin glue was applied in a case of total laryngectomy after closure of the pharynx.
8 
Especially here it was applied not to replace the surgical suture but to provide valuable 
assistance to the tissue synthesis and for local haemostasis. 
 
Figure showing glue being applied in a patient with total laryngectomy www.jorl.net 
 
Sutures were first removed alternatively, and completely removed at 18th post-operative 
day. There was no pharyngo cutaneous fistula. Case was followed up once in a month for 3 
months. There is neither fistula formation nor inflammatory reaction. 
Study 3:  
Fibrin glue was also used in cleft palate repair. It was applied after closure of the muscle 
layer and mucosal layer.  During  post-operative follow up the wound was found to be 
healthy and there is no palatal fistula. 
 
 
Application of tissue glue in cleft palate repair 
 
Study 4:  
Tissue glue is used in external laryngocele surgery. Laryngocele was resected from its 
attachments near the thyrohyoid membrane and tissue glue is applied to seal the defect in 
the thyrohyoid membrane. No recurrence was noted in the one year follow up period. 
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Image showing tissue glue being applied after laryngocele excision 
 
Study 5:  
CSF leak repaired through bicoronal approach. Bicoronal approach was used to expose 
anterior table of the frontal sinus. A window was created in the anterior table of the frontal 
sinus using the fissure burr. The interior of the frontal sinus was visualised and the leak site 
was identified over the posterior table of the left frontal sinus which was sealed using tissue 
glue and abdominal fat. No recurrence was noted in the 6 months follow up period. 
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Tissue glue used in CSF leak repair 
 
Discussion:  
Fibrin glues are used since 1940. These are the most commonly used tissue adhesives.  
Mechanism of adhesion: 
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The principle of biological sealing:  
In the last step of the coagulation cascade fibrinogen is transformed to fibrin monomers 
which aggregate and form a gel. Concomitantly, thrombin transforms factor XIII to factor 
XIIIa in the presence of calcium ions. Factor XIIIa crosslinks the aggregated fibrin monomers 
to a high molecular weight polymer. The resulting fibrin clot seals off surrounding tissue and 
provides early haemostasis. 
 
 
 
 
FIBRIN GLUE REPRODUCES THE LAST STEP OF THE COAGULATION CASCADE:  
In natural conditions the fibrin clot is degraded after 1-2 days in most tissues. Fibrin  glue 
contains aprotinin- the most effective exogenous antifibrinolytic (clot stabilizer) known to 
inhibit not only plasminogen activation and plasmin binding but most proteases involved in 
clot degradation. It is added to fibrin glue to prolong its stability in vivo up to 9-10 days. 
Factor XIII crosslinks fibrin monomers and also fibrin and fibronectin with the collagen of the 
tissue to which the sealant was applied. 
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The fibrin glue clot contains 30 times the fibrinogen concentration, provides high elasticity 
and 4-5 times greater tensile strength than a normal blood clot.  
Fibrinogen concentration is directly proportional to:  
-  Elasticity of the fibrin clot   
-  Increased tensile strength  
-  Increased adhesive strength 
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                  Blood clot                                                               Fibrin glue clot 
 
All components of a fibrin glue matrix are involved in the process of wound healing.  
 
Advantages of these biologic tissue adhesives:  
-  Good adhesion in wet environment 
-  Minimal tissue irritation  
-  Good sealing without heat development  
-  Curing time is better 
Disadvantages:  
-  There is a minimal risk of transmission of prions by aprotinin with bovine origin 1,3  
-  Cannot be used in arterial bleeding (even heavy venous bleeding is contraindicated)   
-  Cannot be used in persons with allergic heparin induced thrombocytopenia, and who are 
intolerance to bovine products. 
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SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE:  
1.   For epilesional use only. Soft tissue injection carries the risk of an anaphylactoid 
reaction and /or local tissue damage   
2.   Life threatening anaphylactiod reactions and/or thromboembolic complications may 
occur if the preparation is unintentionally applied intravascularly.  
3.   It should be applied as a thin layer. Excessive clot thickness may negatively interfere 
with the products efficacy and wound healing process.  
4.  Fibrin glue contains bovine protein (aprotinin). Even in the strict local application, 
there is a risk of anaphylactoid reaction, linked to the presence of bovine aprotinin. 
The risk seems higher in case of previous exposure even it was well tolerated.   
5.   Therefore any use of aprotinin containing products should be recorded in the 
patient’s records.  
6.   In case of shock, standard medical treatment for shock should be implemented.  
7.   Signs of hypersensivity reactions include hives, generalised urticaria, and tightness 
of the chest, wheezing, hypotension, and anaphylaxis. If these symptoms occur the 
administration has to be discontinued immediately.  
8.  Thrombin and factor XIII are made from human plasma. Standard measures to 
prevent infections resulting from the use of medicinal products prepared from 
human blood or plasma include selection of donors, screening of individual 
donations. 
9.  Despite this, the possibility of transmitting infective agents cannot be totally 
excluded. this also applies to unknown or emerging viruses or other pathogens. The 
measures taken are considered effective for enveloped viruses such as HIV, HBV and 
HCV. The measures taken may be of limited value against small non-enveloped 
viruses such as parvovirus B 19 AND HAV.  
10. The hypersensitive and anaphylactoid reactions especially may be seen, if the 
preparation is applied repeatedly, or administered to patients known to be 
hypersensitive to aprotinin or any other constituents of the products. Even if the 
second treatment with fibrin glue was well tolerated, a subsequent administration 
may result in severe anaphylactoid reactions.     
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Other than biologic tissue adhesives some other adhesives also in use.  They are   
-  Synthetic adhesives (cyanoacrylates)  
-  Gelatine resorcinol formaldehyde/glutaraldehyde glues  
-  Albumin glutaraldehyde glue  
Synthetic adhesives:  
This has been described for the first time in 1959. 
1,4.  
But the first short chain cyanoacrylates turned out to be histotoxic and caused distinct 
foreign body reactions. The long chain cyanoacrylates of the second generation are more 
biocompatible.  
5,6 With raising chain length ,toxicity and adhesion strength decrease, 
elasticity and polymerisation time increase.    
First generation:   
-  Methyl cyanoacrylate  
Second generation:  
-  Ethyl 2 cyanoacrylate  
-  n butyl cyanoacrylate  
-  2 octyl cyanoacrylate  
-  Isobutyl cyanoacrylate  
-  N butyl 2 cyanoacrylate + methacryloxysulphone  
Mechanism of adhesion:  
In contact with hydroxide ions (liquids like blood or water, air humidity) the cyanoacrylates 
form long, strong waterproof chains in an exothermic reaction. The resulting polymer leads 
to a stable adhesive bond. The polymerisation time is 20 sec to 2 min. with too much 
moisture the reaction runs too fast for a tissue adhesion. 
Advantages:  
-  Good adhesion in moderate wet environments.   
-  Strong adhesion.  
Disadvantages:  
-  Toxic degradation products.  www.jorl.net 
 
-  Heat generation during polimerization.  
Gelatin resorcinol formaldehyde/glutaraldehyde glues:    
These were introduced on 1966. 
Mechanism of adhesion:  
Resorcinol and dialdehyde react to a 3 dimensional network. Gelatine serves as filler.  
Polimerisation time is 2 min, the degradation products  are much less toxic as those of the  
cyanoacrylates.  
Note: this is not used in otorhinolaryngology widely due to difficult application.  
Albumin glutaraldehyde:    
Mechanism of adhesion:  
The glutaraldehyde molecules band together by covalent bond with the added albumin as 
well as with the proteins of the tissue. The polymerisation time starts immediately after 
mixture of the components. The entire adhesive strength is achieved after 2 min.  
Note: because of its adhesion attributes in wet environments, this adhesive seems to be 
appropriate in otorhinolaryngology.   
Role in ENT:  
Role in otology:    
-  Myringoplasty 7, readaptation of the edges after traumatic rupture  
-  Ossiculoplasty (for both fixation of transplants (cartilage, ossicles) and  
Implants (TORP,PORP)   
-  Fixation of implantable hearing system  
-  Otoplasty 
Role in rhinology:  
-  Septoplasty (sealing of mucosa) ,closure of septal perforations, turbinoplasty, epistaxis.  
-  Fixation of transplants (cartilage, bone) and implants (stents) in repair of CSF leak and 
other surgeries.  
-  Dural plasty .  www.jorl.net 
 
Role in laryngology:  
-  Closure of fistula. 
8  
-  Fixation of transplants and implants. 
 
References :  
1. Schneider 2001 ,march 10. Tissue adhesives in otorhinolaryngology  
2. Pursifull NL,Morey AF, Tissue glues and nonsuturing techniques. Curr opin urol 2007; 17, 
396-401 DOI-10. 1097/ MOU ob013e3282f0d683  
3. Petersen B, Barkun A, Carpenter S, et al. Tissue adhesives and fibrin glues.Gastrointest 
Endosc.2004.60. 327-333, DOI: 10, 1016/S0016-5107 (04) 01564-0   
4. Coover H. Joyner ,shearer N, Wicker T. Chemistry and performance of cyanoacrylate 
adhesives. Special technical papers.1959; 413-417.  
5.Alamouti  D, Von Kobyletzki G, Allard P, Hoffmann K. Ein prospektiver Vergleich von 
octyanoacrylat –Gewebekleberund konventionellen wundverschlussen. Hautarzt. 1999; 50: 
58-59.DOI 10.1007/S001050050867. 
6. Leggat PA ,Smith DR, Kedjarune U. surgical applications of cyanoacrylate adhesives: a 
review of toxicity. ANZ J Surg 2007; 77:209-213.DOI: 10.1080/19338240903241291.  
7. Samuel PR, Roberts AC, Nigam A. The use of indermil (n-butyl cyanoacrylate) in 
otorhinolaryngology and head and neck surgery. A preliminary report on the first 33 
patients. J Laryngol Otol. 1997; 111;536-540.DOI:10.1017/S0022215100137855.  
8. Wiseman S, Hicks W, lr, Loree, kasspooles M, Ringual N. Fibrin glue reinforced closure of 
postlaryngectomy pharyngocutaneous fistula. 